About 12th Human Amyloid Imaging Conference
At HAI 2018 we will continue to emphasize ample lively discussion of core controversies such as: what does the presence of brain amyloid mean, how should it be measured, how does it change, and what does it portend?
Our discussions primarily sprung from brief presentations by active investigators who will report unpublished, cutting-edge research in human imaging of amyloid-beta and/or other biomarkers that pertain to Alzheimer’s-related disease.
To assemble HAI we will accept and peer-review only the most recent, important work, abstract submissions. The 2017 meeting drew more than 365 attendees and showcased 116 posters from research groups spanning North America, Europe, East Asia, and Australia.